Iradimed Co Stock Price on December 12, 2024
| IRMD Stock | USD 54.65 1.30 2.44% |
Below is the normalized historical share price chart for Iradimed Co extending back to July 16, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Iradimed stands at 54.65, as last reported on the 23rd of December, with the highest price reaching 55.15 and the lowest price hitting 52.90 during the day.
If you're considering investing in Iradimed Stock, it is important to understand the factors that can impact its price. Iradimed appears to be very steady, given 3 months investment horizon. Iradimed holds Efficiency (Sharpe) Ratio of 0.0994, which attests that the entity had a 0.0994% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Iradimed, which you can use to evaluate the volatility of the firm. Please utilize Iradimed's Risk Adjusted Performance of 0.0763, market risk adjusted performance of 0.1242, and Downside Deviation of 1.93 to validate if our risk estimates are consistent with your expectations.
At present, Iradimed's Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 0.04, whereas Common Stock Total Equity is forecasted to decline to 1,175. . At present, Iradimed's Price Book Value Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 1.10, whereas Price Earnings Ratio is forecasted to decline to 33.06. Iradimed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of July 2014 | 200 Day MA 46.6512 | 50 Day MA 52.9037 | Beta 0.799 |
Iradimed |
Sharpe Ratio = 0.0994
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IRMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.05 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Iradimed is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Iradimed by adding it to a well-diversified portfolio.
Price Book 8.3014 | Enterprise Value Ebitda 28.9424 | Price Sales 9.7132 | Shares Float 7.1 M | Dividend Share 0.45 |
Related Headline
Neuropace Headline on 12th of December 2024
NeuroPace to Host Investor Day on January 28th in New York C... by gurufocus.com
MOUNTAIN VIEW, Calif., Dec. 12, 2024 -- NeuroPace, Inc. , a medical device company focused on transforming the lives of people living
Iradimed Valuation on December 12, 2024
It is possible to determine the worth of Iradimed on a given historical date. On December 12, 2024 Iradimed was worth 54.8 at the beginning of the trading date compared to the closed value of 54.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Iradimed stock. Still, in general, we apply an absolute valuation method to find Iradimed's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Iradimed where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Iradimed's related companies.
| Open | High | Low | Close | Volume | |
| 56.04 | 56.39 | 55.11 | 55.19 | 133,053 | |
12/12/2024 | 54.80 | 55.03 | 53.58 | 54.43 | 34,303 |
| 54.11 | 54.22 | 52.29 | 52.63 | 72,108 |
| Backtest Iradimed | | | Iradimed History | | | Iradimed Valuation | Previous | Next |
Iradimed Trading Date Momentum on December 12, 2024
| On December 13 2024 Iradimed Co was traded for 52.63 at the closing time. The top price for the day was 54.22 and the lowest listed price was 52.29 . The trading volume for the day was 72.1 K. The trading history from December 13, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.31% . The trading delta at closing time against the current closing price is 1.98% . |
Iradimed Fundamentals Correlations and Trends
By evaluating Iradimed's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Iradimed's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Iradimed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Iradimed Stock history
Iradimed investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Iradimed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Iradimed will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Iradimed stock prices may prove useful in developing a viable investing in Iradimed
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 12.7 M | 13 M | |
| Net Income Applicable To Common Shares | 14.8 M | 15.5 M |
Iradimed Quarterly Net Working Capital |
|
Iradimed Stock Technical Analysis
Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Iradimed Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Iradimed Co cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Iradimed December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Iradimed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iradimed shares will generate the highest return on investment. By undertsting and applying Iradimed stock market strength indicators, traders can identify Iradimed Co entry and exit signals to maximize returns
Iradimed Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Iradimed's price direction in advance. Along with the technical and fundamental analysis of Iradimed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Iradimed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0763 | |||
| Jensen Alpha | 0.1401 | |||
| Total Risk Alpha | 0.1157 | |||
| Sortino Ratio | 0.0784 | |||
| Treynor Ratio | 0.1142 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Iradimed Stock analysis
When running Iradimed's price analysis, check to measure Iradimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iradimed is operating at the current time. Most of Iradimed's value examination focuses on studying past and present price action to predict the probability of Iradimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iradimed's price. Additionally, you may evaluate how the addition of Iradimed to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |